EGTA
Names
[ CAS No. ]:
67-42-5
[ Name ]:
EGTA
[Synonym ]:
Egtazic acid
ethylene glycol bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid
Egtazic
4F 4PP oxalate
CHEL-DE
Ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid
EGTA
AEGT
ethylene glycol bis(2-aminoethyl)tetraacetic acid
(Ethylenebis(oxyethylenenitrilo))tetraacetic acid
Ethylene glycol bis(2-aminoethyl ether)tetraacetic acid
EINECS 200-651-2
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid
Ethylenebis(oxyethylenenitrilo)tetraacetic acid
MFCD00004291
3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioic acid
chel tm-de
GIETA
[ethylenebis(oxyethylenenitrilo)]tetraacetic acid
6,9-Dioxa-3,12-diazatetradecanedioic acid, 3,12-bis(carboxymethyl)-
GEDTA
ebonta
3,6-dioxaoctamethylenedinitrilotetraacetic acid
Biological Activity
[Description]:
[Related Catalog]:
[In Vitro]
[References]
Chemical & Physical Properties
[ Density]:
1.4±0.1 g/cm3
[ Boiling Point ]:
678.0±55.0 °C at 760 mmHg
[ Melting Point ]:
241 °C (dec.)(lit.)
[ Molecular Formula ]:
C14H24N2O10
[ Molecular Weight ]:
380.348
[ Flash Point ]:
363.9±31.5 °C
[ Exact Mass ]:
380.143097
[ PSA ]:
174.14000
[ LogP ]:
-2.53
[ Vapour Pressure ]:
0.0±4.5 mmHg at 25°C
[ Index of Refraction ]:
1.547
[ Storage condition ]:
Store at RT.
[ Water Solubility ]:
slightly soluble
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- AH3760000
- CHEMICAL NAME :
- Acetic acid, (ethylenebis(oxyethylenenitrilo))tetra-
- CAS REGISTRY NUMBER :
- 67-42-5
- BEILSTEIN REFERENCE NO. :
- 1717370
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 5
- MOLECULAR FORMULA :
- C14-H24-N2-O10
- MOLECULAR WEIGHT :
- 380.40
- WISWESSER LINE NOTATION :
- QV1N1VQ2O2O2N1VQ1VQ
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3587 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 16,807,1970
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 150 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NTIS** National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. Volume(issue)/page/year: AD691-490 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84753 No. of Facilities: 111 (estimated) No. of Industries: 1 No. of Occupations: 3 No. of Employees: 664 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84753 No. of Facilities: 103 (estimated) No. of Industries: 1 No. of Occupations: 4 No. of Employees: 1556 (estimated) No. of Female Employees: 1043 (estimated)
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xi
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
2
[ RTECS ]:
AH3760000
[ HS Code ]:
29225000
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 29225000
Articles
Oncotarget 6(5) , 2604-14, (2015)
Major breast cancer predisposition genes, only account for approximately 30% of high-risk breast cancer families and only explain 15% of breast cancer familial relative risk. The HGF growth factor rec...
Immunomodulation by the Pseudomonas syringae HopZ type III effector family in Arabidopsis.PLoS ONE 9(12) , e116152, (2014)
Pseudomonas syringae employs a type III secretion system to inject 20-30 different type III effector (T3SE) proteins into plant host cells. A major role of T3SEs is to suppress plant immune responses ...
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy.Biomaterials 51 , 1-11, (2015)
Targeting cancer metabolism is emerging as a successful strategy for cancer therapy. However, most of the marketed anti-metabolism drugs in cancer therapy do not distinguish normal cells from cancer c...